Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the appointment of Matthew E. Ros as chief ...
Manufacturers are investing in key recombinant vaccines and improving product pipelines, driving growth in the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback